The Centers for Disease Control and Prevention (CDC) said the agency has documented some 5,800 “advanced” COVID-19 cases among the millions of fully vaccinated Americans, who account for far less than 1% of people completely vaccinated.
“Infections from vaccine advances make up a small percentage of people who are fully vaccinated,” the CDC told The Hill in a statement. “The CDC recommends that all eligible people get a COVID-19 vaccine as soon as you have it available.”
The CDC told The Hill on Thursday that about 7 percent of registered advanced cases resulted in hospitalization and that 1 percent of people who contracted infections died.
Advanced COVID-19 infections reported to the CDC were more than 75 million fully vaccinated individuals in the U.S., which occurred in less than 0.008 percent of fully vaccinated individuals. Hospitalizations have occurred at 0.0005 percent of all complete vaccinations and deaths at nearly 0.0001 percent.
Health officials, including the top expert on infectious diseases Anthony FauciAnthony Fauci: Iowa Governor Announces Johnson & Johnson Vaccine Amid Pause: “Would Do It Again” Jill Biden Appears in “Sesame Street” Documentary Despite July 4 Timeline, U.S. they are very far from the immunity of the MORE flock, have noted that COVID-19 vaccines will not be 100% effective, meaning that some vaccinated people will continue to become infected.
“So far, no unexpected patterns have been identified in the case of demographic or vaccine characteristics,” the CDC said.
The health agency asked all eligible people to take the COVID-19 vaccine as soon as possible and fully vaccinated people to maintain precautions against coronavirus, such as wearing a mask and socially distancing themselves, to avoid contracting.
The CDC said advanced cases of COVID-19 were reported among “all people of all ages eligible for vaccination.”
Most advanced infections occurred in women and just over 40% occurred among people aged 60 or older. Nearly 30 percent of advanced cases in fully vaccinated people were asymptomatic, the CDC reported.
“CDC is monitoring cases reported by grouping by patient demographics, geographic location, time since vaccination, vaccine type or batch number, and SARS-CoV-2 lineage,” the agency said.
The federal agency has also developed a database for state health officials to enter and organize data on these advanced cases. “When available,” the CDC said, samples will be collected for genomic sequencing to find out if certain variants caused the infection.
The Pfizer-BioNTech vaccine was reported to be 95% effective against symptomatic cases in trials and, in general, 91% effective against any symptoms and the Modern vaccine documented 94% efficacy against symptomatic cases in trials and an overall efficacy of 90% six months after the second dose.
Johnson & Johnson vaccine was 66% effective in trials worldwide and 72% effective against moderate and severe cases of COVID-19 in the US